Meeting
2014 ASCO Quality Care Symposium
Comparative effectiveness of first-line chemotherapies in advanced non-small cell lung cancer.
Authors
Jennifer T. Chang
Kaiser Permanente, Downey, CA
Jennifer T. Chang, Michele M. Spence, Rita L. Hui, Joanne E. Schottinger, Nazia Rashid, Mirta Millares
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Science of Quality and Cost, Value, and Policy in Quality
Track
Science of Quality,Cost, Value, and Policy in Quality
Sub Track
Studies Using Registries or Combining Large Databases
Citation
J Clin Oncol 32, 2014 (suppl 30; abstr 293)
DOI
10.1200/jco.2014.32.30_suppl.293
Abstract #
293
Poster Bd #
G8
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Retrospective analysis of type of KRAS mutation (mut) and response to first-line platinum-based chemotherapy (PC) in non-small cell lung cancer (NSCLC) patients (pts).
First Author: Wouter Willem Mellema
Poster
2013 ASCO Annual Meeting
Effect of maintenance bevacizumab (Bev) plus pemetrexed (Pem) after first-line cisplatin/Pem/Bev in advanced nonsquamous non-small cell lung cancer (nsNSCLC) on overall survival (OS) of patients (pts) on the AVAPERL (MO22089) phase III randomized trial.
First Author: Achim Rittmeyer
Poster
2011 ASCO Annual Meeting
A phase II randomized trial of anastrozole (A) and fulvestrant (F) as consolidation therapy in postmenopausal women with advanced non-small cell lung cancer who have received first-line platinum-based chemotherapy with or without bevacizumab.
First Author: B. T. McLaughlin
Poster
2024 ASCO Annual Meeting
REZILIENT3: Phase 3 study of zipalertinib plus chemotherapy in patients with previously untreated, advanced nonsquamous non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20 insertions (ex20ins) mutations.
First Author: Helena Alexandra Yu